• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Azilect
    / Teva

    Active Ingredient
    Rasagiline (as mesilate) 1 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    30 X 1 mg

    partial basket chart 12446 9648

    Related information


    Posology: The recommended dose of rasagiline is 1 mg (one tablet of AZILECT) once daily, to be taken with or without levodopa.
    Elderly: No change in dose is required for elderly patients.
    Hepatic impairment: Rasagiline is contraindicated in patients with severe hepatic impairment. Rasagiline use in patients with moderate hepatic impairment should be avoided. Caution should be used when initiating
    treatment with rasagiline in patients with mild hepatic impairment. In case patients progress from mild to moderate hepatic impairment rasagiline should be stopped.
    Renal impairment: No special precautions are required in patients with renal impairment.
    Paediatric population: The safety and efficacy of AZILECT in children and adolescents have not been established. There is no relevant use of AZILECT in the paediatric population in the indication Parkinson’s disease.
    Method of administration: For oral use. AZILECT may be taken with or without food.


    For the treatment of idiopathic Parkinson”s disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.


    Hypersensitivity to the active substance or to any of the excipients. Concomitant treatment with other MAO inhibitors or pethidine. At least 14 days should elapse between discontinuation of rasagiline and initiation of treatment with MAOI inhibitors or pethidine. Patients with severe hepatic insufficiency.

    Special Precautions

    Please contact manufacturer for full information.

    Side Effects

    Please contact manufacturer for full information.

    Drug interactions

    Please contact manufacturer for full information.

    Teva Pharmaceutical Industries Ltd, Israel